Skip to content

Uterine Peristalsis in IVF

Effect of Uterine Peristalsis at the Time of Embryo Transfer on the Outcomes of IVF Cycles: a Prospective Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06036459
Enrollment
117
Registered
2023-09-14
Start date
2023-10-31
Completion date
2026-06-30
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Female

Brief summary

An observational prospective cohort study to evaluate the effect of uterine peristalsis at the time of embryo transfer on IVF clinical outcomes performed in Women's Health hospital, Assiut University, Egypt. Women performing fresh or frozen embryo transfer who do not have any uterine abnormalities will be included in the study

Interventions

OTHERuterine peristalsis

Transabdominal us followed by Transvaginal ultrasonography scans (Sono Ace R5 ) of uterine peristalsis will performed on the day of embryo transfer while the patient lying relaxed in lithotomy position. The probe will be introduced into the vagina as gently as possible to avoid stimulating the cervix. After scanning the mid-sagittal plane of the uterus, the probe will be fixed as steady as possible while a 3 min video of uterine peristalsis will be recorded simultaneously. The records will be analyzed at 4X regular speed using a Video player application by two independent experienced observers. The uterine peristaltic wave frequency will be the mean of the results from each observer.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* • Women undergoing embryo transfer during IVF cycles. * Age: between 20 and 40 years. * Have at least 1 good quality embryo at the time of transfer * Fresh or frozen-thawed cycles. * Any stimulation protocol in fresh cycles, or any endometrial preparation protocol for frozen-thawed cycles

Exclusion criteria

* • Women refusing to participate in clinical research. * Any uncorrected uterine abnormality, such as septum, myoma, adenomyosis, or polyp * Hydrosalpinx without prior disconnection or excision

Design outcomes

Primary

MeasureTime frameDescription
Clinical pregnancy2 weeks after a positive pregnancy testThe presence of intrauterine gestational sac and fetal pole with positive cardiac pulsation by transvaginal ultrasound

Secondary

MeasureTime frameDescription
Biochemical pregnancy2 weeks after embryo transfera positive serum human chorionic gonadotropin
MiscarriageFrom 6 weeks of gestation until 28 weeks of gestationPregnancy loss either loss of cardiac pulsation by ultrasound, or spontaneous loss of pregnancy vaginally
Ectopic pregnancythe site of the gestational sac will be assessed 2 weeks after embryo transferPregnancy outside the uterine cavity
Ongoing pregnancyAfter 12 weeks of gestation until deliveryThe presence of a viable pregnancy after 12 weeks of gestation
Live birthFrom 28 weeks of gestation until deliveryDelivery of a living foetus after the age of viability

Contacts

Primary ContactKarim Abdallah, MD
karimsayed88@aun.edu.eg+201270595485

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 11, 2026